Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumours have more than twice the risk of developing learning and memory problems than those treated with SRS alone, a new study has found.
The study was led by Eric L. Chang, M.D., associate professor in the Department of Radiation Oncology at The University of Texas M. D. Anderson Cancer Center.
Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.
Advertisement
Over the last decade, SRS, which uses high-doses of targeted x-rays, has gained acceptance as an initial treatment for tumours that have spread to the brain.
SRS is also commonly used in combination with WBRT, radiation of the entire brain, to treat tumours that are visible and those that may not be detected by diagnostic imaging.
![Headache / Cephalgia]( "Headache / Cephalgia")
A headache literally means 'pain in the head'. It is a common complaint that may occur frequently in some
"Determining how to optimize outcomes with the smallest cost to the quality of life is a treatment decision every radiation oncologist faces," said Chang.
"While both approaches are in practice and both are equally acceptable, data from this trial suggest that oncologists should offer SRS alone as the upfront, initial therapy for patients with up to three brain metastases," Chang added.
In the seven-year study, the researchers observed 58 patients presenting with one to three newly diagnosed brain metastases who were randomized to receive SRS followed by WBRT or SRS alone.
Approximately four months after treatment, 49 percent of patients who received WBRT experienced a decline in learning and memory function compared to 23 percent in those patients who received SRS alone.
"This is a case where the risks of learning dysfunction outweigh the benefits of freedom from progression and tip the scales in favour of using SRS alone. Patients are spared from the side effects of whole brain radiation and we are able to preserve their memory and learning function to a higher degree," said Chang.
"Here the research suggests patients who receive SRS as their initial treatment and then are monitored closely for any recurrence will fare better," Chang added.
The findings of the phase III randomized trial were presented at today's 50th annual meeting of the American Society for Therapeutic Radiology and Oncology.
Source: ANI
RAS/SK
Headache / Cephalgia
A headache literally means 'pain in the head'. It is a common complaint that may occur frequently in some
Advertisement
"Determining how to optimize outcomes with the smallest cost to the quality of life is a treatment decision every radiation oncologist faces," said Chang.
"While both approaches are in practice and both are equally acceptable, data from this trial suggest that oncologists should offer SRS alone as the upfront, initial therapy for patients with up to three brain metastases," Chang added.
In the seven-year study, the researchers observed 58 patients presenting with one to three newly diagnosed brain metastases who were randomized to receive SRS followed by WBRT or SRS alone.
Approximately four months after treatment, 49 percent of patients who received WBRT experienced a decline in learning and memory function compared to 23 percent in those patients who received SRS alone.
"This is a case where the risks of learning dysfunction outweigh the benefits of freedom from progression and tip the scales in favour of using SRS alone. Patients are spared from the side effects of whole brain radiation and we are able to preserve their memory and learning function to a higher degree," said Chang.
"Here the research suggests patients who receive SRS as their initial treatment and then are monitored closely for any recurrence will fare better," Chang added.
The findings of the phase III randomized trial were presented at today's 50th annual meeting of the American Society for Therapeutic Radiology and Oncology.
Source: ANI
RAS/SK
Family History Confers Higher Risk of Brain Tumors
People with a family history of brain cancer have a significantly higher risk of developing the same type of tumors than individuals with no such family history, according to a study released Monday.
Advertisement
 Mobile Use may Increase Kids' Brain Cancer Risk FivefoldKids and teenagers are at an increased risk of developing brain cancer if they use mobile phones, according to an alarming new research. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
